Clinical Trial Update: Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating Isatuximab in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Isatuximab (isatuximab)

Snippet

Sponsor: Sanofi | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2023-11-15